2cureX AB (OSTO:2CUREX) Beta: 2.6380 (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:2CUREX 2cureX AB OSTO:2CUREX
29 GF Score
Price kr1.87
! 3 Warning Signs
View Full Analysis

What is 2cureX AB Beta?

2cureX AB OSTO:2CUREX +1.74% 29 Beta is 2.6380 as of Jul. 21, 2026. GuruFocus rates OSTO:2CUREX with a GF Score™ of 29/100. The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-21), 2cureX AB's Beta is 2.6380.


2cureX AB  (OSTO:2CUREX) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


2cureX AB Beta Related Terms


2cureX AB Beta Historical Data

* Premium members only.

The historical data trend for 2cureX AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2cureX AB Beta Chart

2cureX AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.94 0.71 0.88 0.61 0.22

2cureX AB Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.61 0.32 0.22 0.37

OSTO:2CUREX vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, 2cureX AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


2cureX AB Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 2cureX AB's Beta distribution charts can be found below:

* The bar in red indicates where 2cureX AB's Beta falls into.


OSTO:2CUREX
29GF Score
2cureX AB OSTO:2CUREX
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

2cureX AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.6380 mean?
2cureX AB (OSTO:2CUREX) has a Beta of 2.6380 as of Jul. 21, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for 2cureX AB and its competitors.
Is 2cureX AB's Beta too high?
2cureX AB's current Beta is 2.6380. Overall, 2cureX AB has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does 2cureX AB's Beta compare to VRTX and REGN?
2cureX AB's Beta of 2.6380 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for 2cureX AB and its competitors. 2cureX AB's current Beta is 2.6380. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 2cureX AB stock overvalued right now?
2cureX AB (OSTO:2CUREX) has a current Beta of 2.6380. The current Beta is 2.6380. 2cureX AB's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For 2cureX AB (OSTO:2CUREX), the current Beta is 2.6380 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

2cureX AB Business Description

Other Exchanges 2QE:Germany
Address Fruebjergvej 3, Copenhagen, DNK, DK-2100
2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.
29GF Score

Get the complete analysis for OSTO:2CUREX

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.87
Price